A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?

Johann Tang; Scott Williams; Keen-Hun Tai; Joanne Dean; Gillian Duchesne

doi:10.1016/j.brachy.2006.08.007

A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?

Johann Tang, Scott Williams, Keen-Hun Tai, Joanne Dean, Gillian Duchesne

Epidemiology and Preventive Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

14 Citations (Scopus)

Abstract

We analyzed data from 88 patients with T1aa??T3a, N0, M0 prostate adenocarcinoma treated on a prospective Phase I/II HDRB boost protocol of 16 or 20 Gy in four fractions, without planned androgen deprivation therapy.

Original language	English
Pages (from-to)	256 - 261
Number of pages	6
Journal	Brachytherapy
Volume	5
DOIs	https://doi.org/10.1016/j.brachy.2006.08.007
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.brachy.2006.08.007

Cite this

@article{39a44ad102254b1f8f53da6194f60e36,

title = "A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?",

abstract = "We analyzed data from 88 patients with T1aa??T3a, N0, M0 prostate adenocarcinoma treated on a prospective Phase I/II HDRB boost protocol of 16 or 20 Gy in four fractions, without planned androgen deprivation therapy.",

author = "Johann Tang and Scott Williams and Keen-Hun Tai and Joanne Dean and Gillian Duchesne",

year = "2006",

doi = "10.1016/j.brachy.2006.08.007",

language = "English",

volume = "5",

pages = "256 -- 261",

journal = "Brachytherapy",